Finance

New Dogecoin Payment App 'Such' Debuts Amid Price Decline

Dogecoin plunges 4% as the Dogecoin Foundation-backed app aims to enhance real-world cryptocurrency usage

The Dogecoin Foundation’s affiliated entity House of Doge, alongside Brag House Holdings, has introduced 'Such,' a payments application crafted to f...

Figma Shares Decline Amid Escalating US-Europe Trade Tensions

Investor Concern Grows Over Tariff Impact on Growth-Oriented Software Stocks

Shares of Figma Inc (NYSE: FIG) experienced a notable decline amid renewed fears of trade restrictions between the US and Europe. Despite its cloud-ba...

United States Antimony Enhances Operations with Strategic Montana Facility Acquisition

The acquisition of a critical minerals flotation plant in Radersburg marks a significant step for UAMY’s expansion and ore processing capabilities

United States Antimony Corp (NYSE: UAMY) has secured a fully functional critical minerals flotation facility in Radersburg, Montana, through a $4.75 m...

Corvus Pharmaceuticals Shares Surge Following Promising Phase 1 Eczema Trial Data

Positive cohort 4 results for soquelitinib in moderate-to-severe atopic dermatitis patients drive stock up by 140%

Corvus Pharmaceuticals has reported encouraging data from cohort 4 of its Phase 1 trial investigating soquelitinib in treating moderate-to-severe atop...

ImmunityBio Advances Regulatory Dialogue, Shares Surge Amid Optimism on Bladder Cancer Treatment

ImmunityBio's engagement with FDA signals potential path forward for Anktiva in treating non-muscle-invasive bladder cancer

ImmunityBio Inc. announced it will supply further information to the FDA following a recent Type B meeting concerning its supplemental biologics licen...

Bitcoin's Fear & Greed Index Reveals Bullish Momentum Amid Resistance Challenges

A technical crossover in Bitcoin's sentiment metric suggests improving short-term outlook despite capital flow weaknesses and rejection at key resistance levels.

Bitcoin is currently trading near $90,000 while its Fear & Greed Index displays a notable bullish signal through a 'golden cross,' where the 30-day mo...

Baidu Advances AI User Base and Chip Business Amid Stock Gains

Chinese Tech Giant's Ernie AI Assistant Surpasses 200 Million Monthly Users as IPO Preparations for Chip Unit Kunlunxin Progress

Baidu Inc. reported strong progress in AI adoption with its Ernie Assistant reaching over 200 million monthly active users. The company is also prepar...

New Era Energy & Digital Shares Surge on Strategic Data Center Collaboration

Collaboration with Primary Digital Infrastructure and acquisition of partner stake catalyze investor enthusiasm

New Era Energy & Digital Inc. witnessed a significant uptick in its stock price following the announcement of a strategic partnership with Primary Dig...

Huntington Ingalls Secures Spot on Key $25 Billion Defense Microelectronics Contract

Mission Technologies Division to Provide Critical Engineering Solutions for DoD and Federal Agencies Under Advanced Technology Support Program V

Huntington Ingalls Industries' Mission Technologies unit has been selected as one of twelve contractors on a significant 10-year, $25.4 billion indefi...

Genmab Shares Decline Following Phase 3 Trial Results for Epcoritamab in DLBCL

Mixed Outcomes in EPCORE DLBCL-1 Trial Prompt Investor Concerns Amid Ongoing Drug Development

Genmab A/S announced initial outcomes from the Phase 3 EPCORE DLBCL-1 trial investigating epcoritamab for relapsed or refractory diffuse large B-cell ...

Wall Street Retreats as Treasury Yields Surge Amid Heightened Trade Tensions

Investor Caution Grows Following Presidential Tariff Threats and Shifts in Global Trade Dynamics

Equity markets declined sharply on Tuesday after reopening from a holiday break, influenced by escalating trade friction between the United States and...

FDA Provides Positive Feedback on Mesoblast's Rexlemestrocel-L Cell Therapy for Chronic Back Pain

Mesoblast advances regulatory process with FDA endorsement of pain reduction and opioid use data for allogeneic cell therapy

Mesoblast Limited has received encouraging feedback from the U.S. Food & Drug Administration regarding its potential Biologics License Application sub...